SCHEMBL26036264

SCHEMBL26036264

CCc1ccc(-c2ccc(CCC(=O)Oc3ccc(CC)c(F)c3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.42
▸ FFAR1 O14842 5/20 0.40
▸ FAAH O00519 1/20 0.40
▸ MAPT P10636 1/20 0.39
▸ FFAR4 Q5NUL3 3/20 0.38
▸ F2 P00734 1/20 0.38
▸ PRSS1 P07477 1/20 0.38
▸ PRSS2 P07478 1/20 0.38
▸ PRSS3 P35030 1/20 0.38
▸ TPSAB1 Q15661 1/20 0.38
▸ TPSD1 Q9BZJ3 1/20 0.38
▸ TPSG1 Q9NRR2 1/20 0.38
▸ CYP4F2 P78329 1/20 0.38
▸ CYP4A11 Q02928 1/20 0.38
▸ RARB P10826 2/20 0.37
▸ RARA P10276 1/20 0.37
▸ RARG P13631 1/20 0.37
▸ PDGFRB P09619 1/20 0.37
▸ PDGFRA P16234 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26036272 0.85 KMT2A (0.55) KMT2AFFAR1MAPTCYP4F2CYP4A11
SCHEMBL26036263 0.85 KMT2A (0.55) KMT2AFFAR1MAPTCYP4F2CYP4A11
SCHEMBL12154251 0.81 KMT2A (0.50) KMT2AMAPTF2PRSS1PRSS2
SCHEMBL12154210 0.80 KMT2A (0.59) KMT2AMAPTCYP4F2CYP4A11
SCHEMBL26036299 0.79 FAAH (0.43) KMT2AFFAR1FAAHRARBRARA
SCHEMBL17487626 0.77 FFAR1 (0.41) KMT2AFFAR1FFAR4F2PRSS1
SCHEMBL12154211 0.75 L3MBTL1 (0.51) KMT2AFFAR1MAPTFFAR4F2
SCHEMBL26036266 0.74 KMT2A (0.45) KMT2AFFAR1MAPTFFAR4F2
SCHEMBL12742713 0.74 MAPT (0.45) KMT2AFFAR1MAPTFFAR4PRSS1
SCHEMBL15471662 0.74 RARB (0.43) FAAHRARBRARARARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11739270-B2 Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound DIC CORPORATION (JP) 2023-08-29 — — US disclosed
US-20230131540-A1 LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY ELEMENT AND COMPOUND DIC CORPORATION (JP) 2023-04-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11739270-B2 Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound OCIAD2, PKN2, SKP1 KMT2A 802/4885FFAR1 2739/4885FAAH 3765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback